Efficacy News and Research

RSS
Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

Scientists identify a new way to develop potential drugs for TB

Scientists identify a new way to develop potential drugs for TB

Study of genetically modified immune cells could help improve promising treatment for melanoma

Study of genetically modified immune cells could help improve promising treatment for melanoma

Male circumcision a 'staggeringly under-utilized tool'

Male circumcision a 'staggeringly under-utilized tool'

Effectiveness of candidate malaria vaccine decreases over time, study shows

Effectiveness of candidate malaria vaccine decreases over time, study shows

Blocked bile ducts can be effectively treated with metal stents

Blocked bile ducts can be effectively treated with metal stents

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

New biodegradable nanoparticles deliver inflammation-resolving drugs to sites of tissue injury

New biodegradable nanoparticles deliver inflammation-resolving drugs to sites of tissue injury

Eritoran drug does not reduce risk of death in patients with severe sepsis

Eritoran drug does not reduce risk of death in patients with severe sepsis

Zometa does not prevent bone metastases

Zometa does not prevent bone metastases

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Study finds significant variation over diuretics use in BPD patients

Study finds significant variation over diuretics use in BPD patients

Study: Despite high erectile dysfunction prevalence most patients remain untreated

Study: Despite high erectile dysfunction prevalence most patients remain untreated

Study examines frequency of VCF use between hospitals

Study examines frequency of VCF use between hospitals

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Mesenchymal stem cells safe, effective for treating poor graft function: Study

Mesenchymal stem cells safe, effective for treating poor graft function: Study

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

Harvard’s Wyss Institute to harness Sony DADC's expertise to advance Organs-on-Chips technologies

Harvard’s Wyss Institute to harness Sony DADC's expertise to advance Organs-on-Chips technologies

Study on neoadjuvant cisplatin-based chemotherapy presented at 28th Annual EAU Congress

Study on neoadjuvant cisplatin-based chemotherapy presented at 28th Annual EAU Congress

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.